Clinical Case Database / Category: Patient Management

A practical guide to the use of faecal calprotectin testing

Publication details

Dr Frances Boa, Dr Anet Soubieres, Dr Andrew Poullis, Dr Fhorkan Uddin, Lorna Kent
Foundation Years Journal, volume 9, issue 2, p.12 (123Doc Education, London, February 2015)

Abstract

Abdominal pain with, or without a change in bowel habit is a common presenting symptom in primary care. A majority of these patients will be suffering from functional bowel disorders including functional dyspepsia and irritable bowel syndrome. Indeed, functional bowel disorders make up a significant proportion of referrals to gastroenterology outpatient clinics (up to 60%) (1). The dilemma in primary care is distinguishing a patient with functional symptoms from one with an underlying diagnosis of inflammatory bowel disease. Up to 50% of patients with a functional diagnosis are referred on for unnecessary endoscopic evaluation (1).
Faecal calprotectin is an inflammatory marker, which is released in excess into the bowel when there is inflammation present. It is measured in the stool and has been shown to help in the differential diagnosis of inflammatory bowel disease and irritable bowel syndrome (2).

Access the Clinical Cases Database

A subscription is required to read the full article. Please subscribe using one of the options below.

ProductPriceSubscription
Foundation Years Clinical Cases Database£29.006 months
Add to cart
Foundation Years Clinical Cases Database£39.0012 months
Add to cart

Authors

Dr Frances Boa

St George's University Hospitals NHS Foundation Trust, SW17 0QT
frances.boa@stgeorges.nhs.uk

Dr Anet Soubieres (Corresponding author)

St George's University Hospitals NHS Foundation Trust, SW17 0QT
anet.soubieres@stgeorges.nhs.uk

Dr Andrew Poullis

St George's University Hospitals NHS Foundation Trust, SW17 0QT
andrew.poullis@stgeorges.nhs.uk

Dr Fhorkan Uddin

Chartfield Surgery, 30 Chartfield Avenue, SW15 6HG
fhorkan.uddin@doctors.org.uk

Lorna Kent

Pathology Project Manager, Wandsworth CCG,
73 Upper Richmond Road, East Putney, London, SW15 2SR
lornakent@nhs.net

References

1. British Society of Gastroenterology. Chronic management: IBS/Functional symptoms. Available at: http://www.bsg.org.uk/clinical/commissioning-report/ibs/functional-symptoms.html. Last update 2014. Accessed 9 April 2014.
2. Faecal Calprotectin diagnostic tests for inflammatory diseases of the bowel. NICE diagnostics guidance Oct 2013.
3. Poullis A, Foster R, Mendall MA, Fagerhol MK. Emerging role of calprotectin in gastroenterology. J gastroenterol Hepatol. 2003;18(7):756.
4. Tibble JA, Bjarnason I. Fecal calprotectin as an index in intestinal inflammation. Drugs Today (Brac) 2001; 37(2):85-96
5. Boussac M, Garin J. Calcium-dependent secretion in human neutrophils: a proteomic approach. Electrophoresis 2000;21:665-672.
6. Irritable bowel syndrome in adults: Diagnosis and management of irritable bowel syndrome in primary care. NICE guidelines [CG61]. February 2008.
7. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006; 130:1480.
8. The use of fecal calprotectin and lactoferrin in patients with IBD. Review.Stragier E, Van Assche G.Acta Gastroenterol Belg. 2013 Sep;76(3):322-8. Review.
9. Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn's disease after ileocolonic resection: A prospective pilot study.Yamamoto T, Shiraki M, Bamba T, Umegae S, Matsumoto K.United European Gastroenterol J. 2013 Oct;1(5):368-74. doi: 10.1177/2050640613501818.
10. Fecal calprotectin in pediatric inflammatory bowel disease: a systematic review.Kostakis ID, Cholidou KG, Vaiopoulos AG, Vlachos IS, Perrea D, Vaos G.Dig Dis Sci. 2013 Feb;58(2):309-19. doi: 10.1007/s10620-012-2347-5. Epub 2012 Aug 17. Review.
11. Faecal calprotectin in term and preterm neonates.Kapel N, Campeotto F, Kalach N, Baldassare M, Butel MJ, Dupont C. J Pediatr Gastroenterol Nutr. 2010 Nov;51(5):542-7. doi: 10.1097/MPG.0b013e3181e2ad72. Review.
12. Fecal calprotectin in healthy children.Oord T, Hornung N. Scand J Clin Lab Invest. 2014 Apr;74(3):254-8. doi: 10.3109/00365513.2013.879732. Epub 2014 Feb 25.
13. National Institute for Health and Care Excellence. Clinical guideline 61: irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care. 2008.
14. British Society of Gastroenterology. Chronic management: IBS/Functional symptoms. Available at: http://www.bsg.org.uk/clinical/commissioning-report/ibs/functional-symptoms.html. Last update 2014. Accessed 9 April 2014.

Disclaimers

Conflict Of Interest

The Journal requires that authors disclose any potential conflict of interest that they may have. This is clearly stated in the Journal’s published “Guidelines for Authors”. The Journal follows the Guidelines against Conflict of Interest published in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/urm_full.pdf).

Financial Statement

The authors of this article have not been paid. The Journal is financed by subscriptions and advertising. The Journal does not receive money from any other sources. The decision to accept or refuse this article for publication was free from financial considerations and was solely the responsibility of the Editorial Panel and Editor-in-Chief.

Patient Consent statement

All pictures and investigations shown in this article are shown with the patients’ consent. We require Authors to maintain patients’ anonymity and to obtain consent to report investigations and pictures involving human subjects when anonymity may be compromised. The Journal follows the Guidelines of the Uniform Requirements for Manuscripts (http://www.icmje.org/urm_full.pdf). The Journal requires in its Guidelines for Authors a statement from Authors that “the subject gave informed consent”.

Animal & Human Rights

When reporting experiments on human subjects, the Journal requires authors to indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the HelsinkiDeclaration of 1975, as revised in 2008.

About the Clinical Cases Database

T​he Foundation Years Clinical Cases Database is​ a selection of 600 peer-reviewed clinical cases in the field of patient safety and clinical practice, specifically focused on the clinical information needs of junior doctors, based around the Foundation Year Curriculum programme (MMC). The cases have been chosen to align with the Foundation Year Curriculum.

The database is fully searchable, or can be browsed by medical specialty. Abstracts can be read free of charge, however a subscription is required in order to read the complete cases.